PBS Biotech is thrilled to announce the successful completion of a $17 million funding round, marking a significant milestone in our mission to revolutionize cell therapy development. As a leading provider of innovative, single-use bioreactor systems, we specialize in addressing the unique challenges posed by shear-sensitive cell types, which are critical for the advancement of cell therapies. Our scalable and cost-effective disposable solutions bridge the gap between benchtop research and large-scale cGMP manufacturing, ensuring that researchers can efficiently transition their discoveries from the lab to the market. This recent infusion of capital will empower us to enhance our product offerings further and expand our expert process development services. By fine-tuning our bioreactor systems and accelerating R&D, we are committed to solving the pressing cell culture challenges faced by our clients, thereby expediting their path to commercialization. The support from our investors underscores their confidence in PBS Biotech’s vision and our role in shaping the future of biopharmaceutical manufacturing. As we embark on this exciting new chapter, we remain dedicated to collaborating with industry leaders and innovators to bring breakthrough therapies to life. To learn more about our bioprocessing solutions or how we can assist your research and development needs, please reach out to our sales team at sales@pbsbiotech.com or visit our website at www.pbsbiotech.com. Together, let’s advance the science of cell therapy and make a lasting impact on patient care.
PBS Biotech Secures $17 Million in Funding to Accelerate Innovation in Bioreactor Systems
Recently funded · $17.0MBiotechnology
Get the full PBS Biotech company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
